A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Clinical trial NCT07465289 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07465289
- Sponsor
- UCB Biopharma SRL
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-27
- Primary completion
- 2031-01-23
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.